Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib

Publication date

2005

Authors

Florentinus, S.R.
Nielsen, M.W.
van Dijk, L.
Leufkens, Hubert G MISNI 0000000392454327
Hansen, E.H.
Heerdink, Eibert R.ORCID 0000-0002-5946-7209ISNI 0000000394315283

Editors

Advisors

Supervisors

DOI

Document Type

Article
Open Access logo

License

Abstract

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being

Citation

Florentinus, S R, Nielsen, M W, van Dijk, L, Leufkens, H G M, Hansen, E H & Heerdink, E R 2005, 'Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib', European Journal of Clinical Pharmacology, vol. 61, pp. 157-159.